The study conducted by Aston Group was presented at the XXV Congress of the International Society on Thrombosis and Hemostasis (ISTH)

Publication date: 1 july 2015

On June 25, 2015, the XXV Congress of the International Society on Thrombosis and Hemostasis (ISTH) was held in Toronto.

The report titled "Russian national registry of patients with hemophilia inhibitor: baseline analysis" was presented by Nadezhda Zozulya, M.D. (Russian State Research Center of the Healthcare Ministry). It drew on the data from the earlier study prepared by Aston Clinical (“Analysis of the information from the Registry of patients with hemophilia inhibitor implemented as part of the All-Russian Registry of hemic diseases”). The study covered predominant majority of patients with hemophilia inhibitor across Russia. No other similar study in the world has presented such a large collection of data.

The leading health scientists and practitioners from around the world who work in the field attended the Congress.

For more information regarding the Registry, you may contact Alexey Filipov,Head of Aston Clinical by e-mail a.filipov@aston-group.org, or by phone +7 (495) 620-09-14 / +7 (495) 620-09 -15.